FDA Greenlights Atossa’s (Z)-Endoxifen Study, Advancing Hope for Metastatic Breast Cancer Treatment
Market Chameleon (Tue, 6-Jan 11:48 AM)
Atossa Therapeutics Secures FDA Rare Pediatric Disease Designation for (Z)-Endoxifen, Opening Door to Priority Review Voucher Opportunity
Market Chameleon (Thu, 11-Dec 10:35 AM)
